Loading…

Cytokines Elevated in HIV Elite Controllers Reduce HIV Replication In Vitro and Modulate HIV Restriction Factor Expression

A subset of HIV-infected individuals termed elite controllers (ECs) maintain CD4 T cell counts and control viral replication in the absence of antiretroviral therapy (ART). Systemic cytokine responses may differentiate ECs from subjects with uncontrolled viral replication or from those who require A...

Full description

Saved in:
Bibliographic Details
Published in:Journal of virology 2017-03, Vol.91 (6)
Main Authors: Jacobs, Evan S, Keating, Sheila M, Abdel-Mohsen, Mohamed, Gibb, Stuart L, Heitman, John W, Inglis, Heather C, Martin, Jeffrey N, Zhang, Jinbing, Kaidarova, Zhanna, Deng, Xutao, Wu, Shiquan, Anastos, Kathryn, Crystal, Howard, Villacres, Maria C, Young, Mary, Greenblatt, Ruth M, Landay, Alan L, Gange, Stephen J, Deeks, Steven G, Golub, Elizabeth T, Pillai, Satish K, Norris, Philip J
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c389t-e2763fa36116cbcea48bfe4ba0da0fae9ec69f59e20d5e772953357cfe8ddf973
cites cdi_FETCH-LOGICAL-c389t-e2763fa36116cbcea48bfe4ba0da0fae9ec69f59e20d5e772953357cfe8ddf973
container_end_page
container_issue 6
container_start_page
container_title Journal of virology
container_volume 91
creator Jacobs, Evan S
Keating, Sheila M
Abdel-Mohsen, Mohamed
Gibb, Stuart L
Heitman, John W
Inglis, Heather C
Martin, Jeffrey N
Zhang, Jinbing
Kaidarova, Zhanna
Deng, Xutao
Wu, Shiquan
Anastos, Kathryn
Crystal, Howard
Villacres, Maria C
Young, Mary
Greenblatt, Ruth M
Landay, Alan L
Gange, Stephen J
Deeks, Steven G
Golub, Elizabeth T
Pillai, Satish K
Norris, Philip J
description A subset of HIV-infected individuals termed elite controllers (ECs) maintain CD4 T cell counts and control viral replication in the absence of antiretroviral therapy (ART). Systemic cytokine responses may differentiate ECs from subjects with uncontrolled viral replication or from those who require ART to suppress viral replication. We measured 87 cytokines in four groups of women: 73 ECs, 42 with pharmacologically suppressed viremia (ART), 42 with uncontrolled viral replication (noncontrollers [NCs]), and 48 HIV-uninfected (NEG) subjects. Four cytokines were elevated in ECs but not NCs or ART subjects: CCL14, CCL21, CCL27, and XCL1. In addition, median stromal cell-derived factor-1 (SDF-1) levels were 43% higher in ECs than in NCs. The combination of the five cytokines suppressed R5 and X4 virus replication in resting CD4 T cells, and individually SDF-1β, CCL14, and CCL27 suppressed R5 virus replication, while SDF-1β, CCL21, and CCL14 suppressed X4 virus replication. Functional studies revealed that the combination of the five cytokines upregulated CD69 and CCR5 and downregulated CXCR4 and CCR7 on CD4 T cells. The CD69 and CXCR4 effects were driven by SDF-1, while CCL21 downregulated CCR7. The combination of the EC-associated cytokines induced expression of the anti-HIV host restriction factors IFITM1 and IFITM2 and suppressed expression of RNase L and SAMHD1. These results identify a set of cytokines that are elevated in ECs and define their effects on cellular activation, HIV coreceptor expression, and innate restriction factor expression. This cytokine pattern may be a signature characteristic of HIV-1 elite control, potentially important for HIV therapeutic and curative strategies. Approximately 1% of people infected with HIV control virus replication without taking antiviral medications. These subjects, termed elite controllers (ECs), are known to have stronger immune responses targeting HIV than the typical HIV-infected subject, but the exact mechanisms of how their immune responses control infection are not known. In this study, we identified five soluble immune signaling molecules (cytokines) in the blood that were higher in ECs than in subjects with typical chronic HIV infection. We demonstrated that these cytokines can activate CD4 T cells, the target cells for HIV infection. Furthermore, these five EC-associated cytokines could change expression levels of intrinsic resistance factors, or molecules inside the target cell that fight HIV infection.
doi_str_mv 10.1128/JVI.02051-16
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5331794</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1855786491</sourcerecordid><originalsourceid>FETCH-LOGICAL-c389t-e2763fa36116cbcea48bfe4ba0da0fae9ec69f59e20d5e772953357cfe8ddf973</originalsourceid><addsrcrecordid>eNpVkUFPGzEQRi1EVQL0xrnykUOX2uv1rn1BQqsEUlFVQjTqzXLsWXBx1sHejUp_PSakiJ6s8Ty9mdGH0AklZ5SW4uu3xfyMlITTgtZ7aEKJFAXntNpHE0LKsuBM_DpAhyn9JoRWVV19RAelIJxRwibob_s0hAfXQ8JTDxs9gMWux1fzRa7dALgN_RCD9xATvgE7Gtg2b2DtndGDCz2e93jhMoR1b_H3YEefNTsqDdGZLTXTZggRT_-sI6SUf47Rh077BJ927xH6OZvetlfF9Y_LeXtxXRgm5FBA2dSs06ymtDZLA7oSyw6qpSZWk06DBFPLjksoieXQNKXkjPHGdCCs7WTDjtD5q3c9LldgDeSDtFfr6FY6Pqmgnfq_07t7dRc2KntoI6ssON0JYngc80lq5ZIB73UPYUyKCs4bUVeSZvTLK2piSClC9zaGEvUSl8pxqW1citYZ__x-tTf4Xz7sGUqikxE</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1855786491</pqid></control><display><type>article</type><title>Cytokines Elevated in HIV Elite Controllers Reduce HIV Replication In Vitro and Modulate HIV Restriction Factor Expression</title><source>Open Access: PubMed Central</source><source>American Society for Microbiology Journals</source><creator>Jacobs, Evan S ; Keating, Sheila M ; Abdel-Mohsen, Mohamed ; Gibb, Stuart L ; Heitman, John W ; Inglis, Heather C ; Martin, Jeffrey N ; Zhang, Jinbing ; Kaidarova, Zhanna ; Deng, Xutao ; Wu, Shiquan ; Anastos, Kathryn ; Crystal, Howard ; Villacres, Maria C ; Young, Mary ; Greenblatt, Ruth M ; Landay, Alan L ; Gange, Stephen J ; Deeks, Steven G ; Golub, Elizabeth T ; Pillai, Satish K ; Norris, Philip J</creator><contributor>Silvestri, Guido</contributor><creatorcontrib>Jacobs, Evan S ; Keating, Sheila M ; Abdel-Mohsen, Mohamed ; Gibb, Stuart L ; Heitman, John W ; Inglis, Heather C ; Martin, Jeffrey N ; Zhang, Jinbing ; Kaidarova, Zhanna ; Deng, Xutao ; Wu, Shiquan ; Anastos, Kathryn ; Crystal, Howard ; Villacres, Maria C ; Young, Mary ; Greenblatt, Ruth M ; Landay, Alan L ; Gange, Stephen J ; Deeks, Steven G ; Golub, Elizabeth T ; Pillai, Satish K ; Norris, Philip J ; Silvestri, Guido</creatorcontrib><description>A subset of HIV-infected individuals termed elite controllers (ECs) maintain CD4 T cell counts and control viral replication in the absence of antiretroviral therapy (ART). Systemic cytokine responses may differentiate ECs from subjects with uncontrolled viral replication or from those who require ART to suppress viral replication. We measured 87 cytokines in four groups of women: 73 ECs, 42 with pharmacologically suppressed viremia (ART), 42 with uncontrolled viral replication (noncontrollers [NCs]), and 48 HIV-uninfected (NEG) subjects. Four cytokines were elevated in ECs but not NCs or ART subjects: CCL14, CCL21, CCL27, and XCL1. In addition, median stromal cell-derived factor-1 (SDF-1) levels were 43% higher in ECs than in NCs. The combination of the five cytokines suppressed R5 and X4 virus replication in resting CD4 T cells, and individually SDF-1β, CCL14, and CCL27 suppressed R5 virus replication, while SDF-1β, CCL21, and CCL14 suppressed X4 virus replication. Functional studies revealed that the combination of the five cytokines upregulated CD69 and CCR5 and downregulated CXCR4 and CCR7 on CD4 T cells. The CD69 and CXCR4 effects were driven by SDF-1, while CCL21 downregulated CCR7. The combination of the EC-associated cytokines induced expression of the anti-HIV host restriction factors IFITM1 and IFITM2 and suppressed expression of RNase L and SAMHD1. These results identify a set of cytokines that are elevated in ECs and define their effects on cellular activation, HIV coreceptor expression, and innate restriction factor expression. This cytokine pattern may be a signature characteristic of HIV-1 elite control, potentially important for HIV therapeutic and curative strategies. Approximately 1% of people infected with HIV control virus replication without taking antiviral medications. These subjects, termed elite controllers (ECs), are known to have stronger immune responses targeting HIV than the typical HIV-infected subject, but the exact mechanisms of how their immune responses control infection are not known. In this study, we identified five soluble immune signaling molecules (cytokines) in the blood that were higher in ECs than in subjects with typical chronic HIV infection. We demonstrated that these cytokines can activate CD4 T cells, the target cells for HIV infection. Furthermore, these five EC-associated cytokines could change expression levels of intrinsic resistance factors, or molecules inside the target cell that fight HIV infection. This study is significant in that it identified cytokines elevated in subjects with a good immune response against HIV and defined potential mechanisms as to how these cytokines could induce resistance to the virus in target cells.</description><identifier>ISSN: 0022-538X</identifier><identifier>EISSN: 1098-5514</identifier><identifier>DOI: 10.1128/JVI.02051-16</identifier><identifier>PMID: 28053103</identifier><language>eng</language><publisher>United States: American Society for Microbiology</publisher><subject>Adult ; Antigens, Differentiation - biosynthesis ; CD4-Positive T-Lymphocytes - virology ; Cytokines - metabolism ; Female ; Gene Expression Regulation ; HIV - immunology ; HIV - physiology ; HIV Infections - immunology ; HIV Long-Term Survivors ; Humans ; Membrane Proteins - biosynthesis ; Middle Aged ; Pathogenesis and Immunity ; Plasma - chemistry ; Receptors, HIV - biosynthesis ; Virus Replication - drug effects</subject><ispartof>Journal of virology, 2017-03, Vol.91 (6)</ispartof><rights>Copyright © 2017 American Society for Microbiology.</rights><rights>Copyright © 2017 American Society for Microbiology. 2017 American Society for Microbiology</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c389t-e2763fa36116cbcea48bfe4ba0da0fae9ec69f59e20d5e772953357cfe8ddf973</citedby><cites>FETCH-LOGICAL-c389t-e2763fa36116cbcea48bfe4ba0da0fae9ec69f59e20d5e772953357cfe8ddf973</cites><orcidid>0000-0003-0526-2088</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5331794/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5331794/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,3186,27923,27924,53790,53792</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28053103$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Silvestri, Guido</contributor><creatorcontrib>Jacobs, Evan S</creatorcontrib><creatorcontrib>Keating, Sheila M</creatorcontrib><creatorcontrib>Abdel-Mohsen, Mohamed</creatorcontrib><creatorcontrib>Gibb, Stuart L</creatorcontrib><creatorcontrib>Heitman, John W</creatorcontrib><creatorcontrib>Inglis, Heather C</creatorcontrib><creatorcontrib>Martin, Jeffrey N</creatorcontrib><creatorcontrib>Zhang, Jinbing</creatorcontrib><creatorcontrib>Kaidarova, Zhanna</creatorcontrib><creatorcontrib>Deng, Xutao</creatorcontrib><creatorcontrib>Wu, Shiquan</creatorcontrib><creatorcontrib>Anastos, Kathryn</creatorcontrib><creatorcontrib>Crystal, Howard</creatorcontrib><creatorcontrib>Villacres, Maria C</creatorcontrib><creatorcontrib>Young, Mary</creatorcontrib><creatorcontrib>Greenblatt, Ruth M</creatorcontrib><creatorcontrib>Landay, Alan L</creatorcontrib><creatorcontrib>Gange, Stephen J</creatorcontrib><creatorcontrib>Deeks, Steven G</creatorcontrib><creatorcontrib>Golub, Elizabeth T</creatorcontrib><creatorcontrib>Pillai, Satish K</creatorcontrib><creatorcontrib>Norris, Philip J</creatorcontrib><title>Cytokines Elevated in HIV Elite Controllers Reduce HIV Replication In Vitro and Modulate HIV Restriction Factor Expression</title><title>Journal of virology</title><addtitle>J Virol</addtitle><description>A subset of HIV-infected individuals termed elite controllers (ECs) maintain CD4 T cell counts and control viral replication in the absence of antiretroviral therapy (ART). Systemic cytokine responses may differentiate ECs from subjects with uncontrolled viral replication or from those who require ART to suppress viral replication. We measured 87 cytokines in four groups of women: 73 ECs, 42 with pharmacologically suppressed viremia (ART), 42 with uncontrolled viral replication (noncontrollers [NCs]), and 48 HIV-uninfected (NEG) subjects. Four cytokines were elevated in ECs but not NCs or ART subjects: CCL14, CCL21, CCL27, and XCL1. In addition, median stromal cell-derived factor-1 (SDF-1) levels were 43% higher in ECs than in NCs. The combination of the five cytokines suppressed R5 and X4 virus replication in resting CD4 T cells, and individually SDF-1β, CCL14, and CCL27 suppressed R5 virus replication, while SDF-1β, CCL21, and CCL14 suppressed X4 virus replication. Functional studies revealed that the combination of the five cytokines upregulated CD69 and CCR5 and downregulated CXCR4 and CCR7 on CD4 T cells. The CD69 and CXCR4 effects were driven by SDF-1, while CCL21 downregulated CCR7. The combination of the EC-associated cytokines induced expression of the anti-HIV host restriction factors IFITM1 and IFITM2 and suppressed expression of RNase L and SAMHD1. These results identify a set of cytokines that are elevated in ECs and define their effects on cellular activation, HIV coreceptor expression, and innate restriction factor expression. This cytokine pattern may be a signature characteristic of HIV-1 elite control, potentially important for HIV therapeutic and curative strategies. Approximately 1% of people infected with HIV control virus replication without taking antiviral medications. These subjects, termed elite controllers (ECs), are known to have stronger immune responses targeting HIV than the typical HIV-infected subject, but the exact mechanisms of how their immune responses control infection are not known. In this study, we identified five soluble immune signaling molecules (cytokines) in the blood that were higher in ECs than in subjects with typical chronic HIV infection. We demonstrated that these cytokines can activate CD4 T cells, the target cells for HIV infection. Furthermore, these five EC-associated cytokines could change expression levels of intrinsic resistance factors, or molecules inside the target cell that fight HIV infection. This study is significant in that it identified cytokines elevated in subjects with a good immune response against HIV and defined potential mechanisms as to how these cytokines could induce resistance to the virus in target cells.</description><subject>Adult</subject><subject>Antigens, Differentiation - biosynthesis</subject><subject>CD4-Positive T-Lymphocytes - virology</subject><subject>Cytokines - metabolism</subject><subject>Female</subject><subject>Gene Expression Regulation</subject><subject>HIV - immunology</subject><subject>HIV - physiology</subject><subject>HIV Infections - immunology</subject><subject>HIV Long-Term Survivors</subject><subject>Humans</subject><subject>Membrane Proteins - biosynthesis</subject><subject>Middle Aged</subject><subject>Pathogenesis and Immunity</subject><subject>Plasma - chemistry</subject><subject>Receptors, HIV - biosynthesis</subject><subject>Virus Replication - drug effects</subject><issn>0022-538X</issn><issn>1098-5514</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><recordid>eNpVkUFPGzEQRi1EVQL0xrnykUOX2uv1rn1BQqsEUlFVQjTqzXLsWXBx1sHejUp_PSakiJ6s8Ty9mdGH0AklZ5SW4uu3xfyMlITTgtZ7aEKJFAXntNpHE0LKsuBM_DpAhyn9JoRWVV19RAelIJxRwibob_s0hAfXQ8JTDxs9gMWux1fzRa7dALgN_RCD9xATvgE7Gtg2b2DtndGDCz2e93jhMoR1b_H3YEefNTsqDdGZLTXTZggRT_-sI6SUf47Rh077BJ927xH6OZvetlfF9Y_LeXtxXRgm5FBA2dSs06ymtDZLA7oSyw6qpSZWk06DBFPLjksoieXQNKXkjPHGdCCs7WTDjtD5q3c9LldgDeSDtFfr6FY6Pqmgnfq_07t7dRc2KntoI6ssON0JYngc80lq5ZIB73UPYUyKCs4bUVeSZvTLK2piSClC9zaGEvUSl8pxqW1citYZ__x-tTf4Xz7sGUqikxE</recordid><startdate>20170315</startdate><enddate>20170315</enddate><creator>Jacobs, Evan S</creator><creator>Keating, Sheila M</creator><creator>Abdel-Mohsen, Mohamed</creator><creator>Gibb, Stuart L</creator><creator>Heitman, John W</creator><creator>Inglis, Heather C</creator><creator>Martin, Jeffrey N</creator><creator>Zhang, Jinbing</creator><creator>Kaidarova, Zhanna</creator><creator>Deng, Xutao</creator><creator>Wu, Shiquan</creator><creator>Anastos, Kathryn</creator><creator>Crystal, Howard</creator><creator>Villacres, Maria C</creator><creator>Young, Mary</creator><creator>Greenblatt, Ruth M</creator><creator>Landay, Alan L</creator><creator>Gange, Stephen J</creator><creator>Deeks, Steven G</creator><creator>Golub, Elizabeth T</creator><creator>Pillai, Satish K</creator><creator>Norris, Philip J</creator><general>American Society for Microbiology</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-0526-2088</orcidid></search><sort><creationdate>20170315</creationdate><title>Cytokines Elevated in HIV Elite Controllers Reduce HIV Replication In Vitro and Modulate HIV Restriction Factor Expression</title><author>Jacobs, Evan S ; Keating, Sheila M ; Abdel-Mohsen, Mohamed ; Gibb, Stuart L ; Heitman, John W ; Inglis, Heather C ; Martin, Jeffrey N ; Zhang, Jinbing ; Kaidarova, Zhanna ; Deng, Xutao ; Wu, Shiquan ; Anastos, Kathryn ; Crystal, Howard ; Villacres, Maria C ; Young, Mary ; Greenblatt, Ruth M ; Landay, Alan L ; Gange, Stephen J ; Deeks, Steven G ; Golub, Elizabeth T ; Pillai, Satish K ; Norris, Philip J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c389t-e2763fa36116cbcea48bfe4ba0da0fae9ec69f59e20d5e772953357cfe8ddf973</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Adult</topic><topic>Antigens, Differentiation - biosynthesis</topic><topic>CD4-Positive T-Lymphocytes - virology</topic><topic>Cytokines - metabolism</topic><topic>Female</topic><topic>Gene Expression Regulation</topic><topic>HIV - immunology</topic><topic>HIV - physiology</topic><topic>HIV Infections - immunology</topic><topic>HIV Long-Term Survivors</topic><topic>Humans</topic><topic>Membrane Proteins - biosynthesis</topic><topic>Middle Aged</topic><topic>Pathogenesis and Immunity</topic><topic>Plasma - chemistry</topic><topic>Receptors, HIV - biosynthesis</topic><topic>Virus Replication - drug effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Jacobs, Evan S</creatorcontrib><creatorcontrib>Keating, Sheila M</creatorcontrib><creatorcontrib>Abdel-Mohsen, Mohamed</creatorcontrib><creatorcontrib>Gibb, Stuart L</creatorcontrib><creatorcontrib>Heitman, John W</creatorcontrib><creatorcontrib>Inglis, Heather C</creatorcontrib><creatorcontrib>Martin, Jeffrey N</creatorcontrib><creatorcontrib>Zhang, Jinbing</creatorcontrib><creatorcontrib>Kaidarova, Zhanna</creatorcontrib><creatorcontrib>Deng, Xutao</creatorcontrib><creatorcontrib>Wu, Shiquan</creatorcontrib><creatorcontrib>Anastos, Kathryn</creatorcontrib><creatorcontrib>Crystal, Howard</creatorcontrib><creatorcontrib>Villacres, Maria C</creatorcontrib><creatorcontrib>Young, Mary</creatorcontrib><creatorcontrib>Greenblatt, Ruth M</creatorcontrib><creatorcontrib>Landay, Alan L</creatorcontrib><creatorcontrib>Gange, Stephen J</creatorcontrib><creatorcontrib>Deeks, Steven G</creatorcontrib><creatorcontrib>Golub, Elizabeth T</creatorcontrib><creatorcontrib>Pillai, Satish K</creatorcontrib><creatorcontrib>Norris, Philip J</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of virology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Jacobs, Evan S</au><au>Keating, Sheila M</au><au>Abdel-Mohsen, Mohamed</au><au>Gibb, Stuart L</au><au>Heitman, John W</au><au>Inglis, Heather C</au><au>Martin, Jeffrey N</au><au>Zhang, Jinbing</au><au>Kaidarova, Zhanna</au><au>Deng, Xutao</au><au>Wu, Shiquan</au><au>Anastos, Kathryn</au><au>Crystal, Howard</au><au>Villacres, Maria C</au><au>Young, Mary</au><au>Greenblatt, Ruth M</au><au>Landay, Alan L</au><au>Gange, Stephen J</au><au>Deeks, Steven G</au><au>Golub, Elizabeth T</au><au>Pillai, Satish K</au><au>Norris, Philip J</au><au>Silvestri, Guido</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Cytokines Elevated in HIV Elite Controllers Reduce HIV Replication In Vitro and Modulate HIV Restriction Factor Expression</atitle><jtitle>Journal of virology</jtitle><addtitle>J Virol</addtitle><date>2017-03-15</date><risdate>2017</risdate><volume>91</volume><issue>6</issue><issn>0022-538X</issn><eissn>1098-5514</eissn><abstract>A subset of HIV-infected individuals termed elite controllers (ECs) maintain CD4 T cell counts and control viral replication in the absence of antiretroviral therapy (ART). Systemic cytokine responses may differentiate ECs from subjects with uncontrolled viral replication or from those who require ART to suppress viral replication. We measured 87 cytokines in four groups of women: 73 ECs, 42 with pharmacologically suppressed viremia (ART), 42 with uncontrolled viral replication (noncontrollers [NCs]), and 48 HIV-uninfected (NEG) subjects. Four cytokines were elevated in ECs but not NCs or ART subjects: CCL14, CCL21, CCL27, and XCL1. In addition, median stromal cell-derived factor-1 (SDF-1) levels were 43% higher in ECs than in NCs. The combination of the five cytokines suppressed R5 and X4 virus replication in resting CD4 T cells, and individually SDF-1β, CCL14, and CCL27 suppressed R5 virus replication, while SDF-1β, CCL21, and CCL14 suppressed X4 virus replication. Functional studies revealed that the combination of the five cytokines upregulated CD69 and CCR5 and downregulated CXCR4 and CCR7 on CD4 T cells. The CD69 and CXCR4 effects were driven by SDF-1, while CCL21 downregulated CCR7. The combination of the EC-associated cytokines induced expression of the anti-HIV host restriction factors IFITM1 and IFITM2 and suppressed expression of RNase L and SAMHD1. These results identify a set of cytokines that are elevated in ECs and define their effects on cellular activation, HIV coreceptor expression, and innate restriction factor expression. This cytokine pattern may be a signature characteristic of HIV-1 elite control, potentially important for HIV therapeutic and curative strategies. Approximately 1% of people infected with HIV control virus replication without taking antiviral medications. These subjects, termed elite controllers (ECs), are known to have stronger immune responses targeting HIV than the typical HIV-infected subject, but the exact mechanisms of how their immune responses control infection are not known. In this study, we identified five soluble immune signaling molecules (cytokines) in the blood that were higher in ECs than in subjects with typical chronic HIV infection. We demonstrated that these cytokines can activate CD4 T cells, the target cells for HIV infection. Furthermore, these five EC-associated cytokines could change expression levels of intrinsic resistance factors, or molecules inside the target cell that fight HIV infection. This study is significant in that it identified cytokines elevated in subjects with a good immune response against HIV and defined potential mechanisms as to how these cytokines could induce resistance to the virus in target cells.</abstract><cop>United States</cop><pub>American Society for Microbiology</pub><pmid>28053103</pmid><doi>10.1128/JVI.02051-16</doi><orcidid>https://orcid.org/0000-0003-0526-2088</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0022-538X
ispartof Journal of virology, 2017-03, Vol.91 (6)
issn 0022-538X
1098-5514
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5331794
source Open Access: PubMed Central; American Society for Microbiology Journals
subjects Adult
Antigens, Differentiation - biosynthesis
CD4-Positive T-Lymphocytes - virology
Cytokines - metabolism
Female
Gene Expression Regulation
HIV - immunology
HIV - physiology
HIV Infections - immunology
HIV Long-Term Survivors
Humans
Membrane Proteins - biosynthesis
Middle Aged
Pathogenesis and Immunity
Plasma - chemistry
Receptors, HIV - biosynthesis
Virus Replication - drug effects
title Cytokines Elevated in HIV Elite Controllers Reduce HIV Replication In Vitro and Modulate HIV Restriction Factor Expression
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-12T11%3A50%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Cytokines%20Elevated%20in%20HIV%20Elite%20Controllers%20Reduce%20HIV%20Replication%20In%20Vitro%20and%20Modulate%20HIV%20Restriction%20Factor%20Expression&rft.jtitle=Journal%20of%20virology&rft.au=Jacobs,%20Evan%20S&rft.date=2017-03-15&rft.volume=91&rft.issue=6&rft.issn=0022-538X&rft.eissn=1098-5514&rft_id=info:doi/10.1128/JVI.02051-16&rft_dat=%3Cproquest_pubme%3E1855786491%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c389t-e2763fa36116cbcea48bfe4ba0da0fae9ec69f59e20d5e772953357cfe8ddf973%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1855786491&rft_id=info:pmid/28053103&rfr_iscdi=true